ENDOTAK RELIANCE, ENDOTAK RELIANCE 4-SITE
FDA premarket approval P910073/S115 · decided 2013-02-14
Approval details
- PMA number
- P910073
- Supplement
- S115
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ENDOTAK RELIANCE, ENDOTAK RELIANCE 4-SITE
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2013-01-04
- Decision date
- 2013-02-14
- Days to decision
- 41 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- APPROVAL FOR LABELING CHANGES FOR THE DEVICES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.